Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-045418
Filing Date
2005-03-09
Accepted
2005-03-09 14:31:41
Documents
7
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 954863
2 LIST OF SUBSIDIARIES OF THE REGISTRANT dex211.htm EX-21.1 1348
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS dex231.htm EX-23.1 1867
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9209
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9394
6 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 4082
7 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 4072
  Complete submission text file 0001193125-05-045418.txt   987161
Mailing Address 6330 QUADRANGLE DR SUITE 240 CHAPEL HILL NC 27514
Business Address 6330 QUADRANGLE DR SUITE 240 CHAPEL HILL NC 27514 9194900012
POZEN INC /NC (Filer) CIK: 0001059790 (see all company filings)

EIN.: 621657552 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31719 | Film No.: 05669063
SIC: 2834 Pharmaceutical Preparations